Wnt5a and Sfrp5 appear to be critical players in the regulation of systemic inflammation in obesity and glucose homeostasis, as well as mediators between adipose tissue and other key metabolic organs, including the liver and the pancreas. The gene discussed is SFRP5; the disease is obesity disorder.